194 related articles for article (PubMed ID: 10194116)
1. Human cytomegalovirus infection of human hematopoietic progenitor cells.
Maciejewski JP; St Jeor SC
Leuk Lymphoma; 1999 Mar; 33(1-2):1-13. PubMed ID: 10194116
[TBL] [Abstract][Full Text] [Related]
2. Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency.
Zhuravskaya T; Maciejewski JP; Netski DM; Bruening E; Mackintosh FR; St Jeor S
Blood; 1997 Sep; 90(6):2482-91. PubMed ID: 9310501
[TBL] [Abstract][Full Text] [Related]
3. Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34
Crawford LB; Caposio P; Kreklywich C; Pham AH; Hancock MH; Jones TA; Smith PP; Yurochko AD; Nelson JA; Streblow DN
mBio; 2019 Aug; 10(4):. PubMed ID: 31431555
[TBL] [Abstract][Full Text] [Related]
4. CD34
Crawford LB; Hancock MH; Struthers HM; Streblow DN; Yurochko AD; Caposio P; Goodrum FD; Nelson JA
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177198
[TBL] [Abstract][Full Text] [Related]
5. Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state.
Shnayder M; Nachshon A; Rozman B; Bernshtein B; Lavi M; Fein N; Poole E; Avdic S; Blyth E; Gottlieb D; Abendroth A; Slobedman B; Sinclair J; Stern-Ginossar N; Schwartz M
Elife; 2020 Jan; 9():. PubMed ID: 31967545
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
Noriega VM; Haye KK; Kraus TA; Kowalsky SR; Ge Y; Moran TM; Tortorella D
J Virol; 2014 Aug; 88(16):9391-405. PubMed ID: 24920803
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.
Goodrum FD; Jordan CT; High K; Shenk T
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16255-60. PubMed ID: 12456880
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells.
Sindre H; Tjøonnfjord GE; Rollag H; Ranneberg-Nilsen T; Veiby OP; Beck S; Degré M; Hestdal K
Blood; 1996 Dec; 88(12):4526-33. PubMed ID: 8977244
[TBL] [Abstract][Full Text] [Related]
9. Human cytomegalovirus reprogrammes haematopoietic progenitor cells into immunosuppressive monocytes to achieve latency.
Zhu D; Pan C; Sheng J; Liang H; Bian Z; Liu Y; Trang P; Wu J; Liu F; Zhang CY; Zen K
Nat Microbiol; 2018 Apr; 3(4):503-513. PubMed ID: 29588542
[TBL] [Abstract][Full Text] [Related]
10. The use of primary human cells (fibroblasts, monocytes, and others) to assess human cytomegalovirus function.
Poole E; Reeves M; Sinclair JH
Methods Mol Biol; 2014; 1119():81-98. PubMed ID: 24639219
[TBL] [Abstract][Full Text] [Related]
11. Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34
Kim JH; Collins-McMillen D; Buehler JC; Goodrum FD; Yurochko AD
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974567
[TBL] [Abstract][Full Text] [Related]
12. Infection of hematopoietic progenitor cells by human cytomegalovirus.
Maciejewski JP; Bruening EE; Donahue RE; Mocarski ES; Young NS; St Jeor SC
Blood; 1992 Jul; 80(1):170-8. PubMed ID: 1377049
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model.
Smith MS; Goldman DC; Bailey AS; Pfaffle DL; Kreklywich CN; Spencer DB; Othieno FA; Streblow DN; Garcia JV; Fleming WH; Nelson JA
Cell Host Microbe; 2010 Sep; 8(3):284-91. PubMed ID: 20833379
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus reactivation in bone-marrow-derived granulocyte/monocyte progenitor cells and mature monocytes.
Prösch S; Döcke WD; Reinke P; Volk HD; Krüger DH
Intervirology; 1999; 42(5-6):308-13. PubMed ID: 10702711
[TBL] [Abstract][Full Text] [Related]
15. Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations.
Goodrum F; Jordan CT; Terhune SS; High K; Shenk T
Blood; 2004 Aug; 104(3):687-95. PubMed ID: 15090458
[TBL] [Abstract][Full Text] [Related]
16. Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow.
von Laer D; Meyer-Koenig U; Serr A; Finke J; Kanz L; Fauser AA; Neumann-Haefelin D; Brugger W; Hufert FT
Blood; 1995 Dec; 86(11):4086-90. PubMed ID: 7492764
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic long-term culture (hLTC) for human cytomegalovirus latency and reactivation.
Umashankar M; Goodrum F
Methods Mol Biol; 2014; 1119():99-112. PubMed ID: 24639220
[TBL] [Abstract][Full Text] [Related]
18. Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.
Humby MS; O'Connor CM
J Virol; 2015 Dec; 90(6):2959-70. PubMed ID: 26719258
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus reactivation from latency: validation of a "switch" model in vitro.
Arcangeletti MC; Vasile Simone R; Rodighiero I; De Conto F; Medici MC; Maccari C; Chezzi C; Calderaro A
Virol J; 2016 Oct; 13(1):179. PubMed ID: 27770817
[TBL] [Abstract][Full Text] [Related]
20. Human Cytomegalovirus miR-US25-1 Targets the GTPase RhoA To Inhibit CD34
Diggins NL; Crawford LB; Hancock MH; Mitchell J; Nelson JA
mBio; 2021 Apr; 12(2):. PubMed ID: 33824207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]